Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.8 |
mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.0094 | 0.8 |
mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |